These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 24718482)
21. Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma. Zhang QB; Sun HC; Zhang KZ; Jia QA; Bu Y; Wang M; Chai ZT; Zhang QB; Wang WQ; Kong LQ; Zhu XD; Lu L; Wu WZ; Wang L; Tang ZY PLoS One; 2013; 8(2):e55945. PubMed ID: 23409093 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction. Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747 [TBL] [Abstract][Full Text] [Related]
23. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Williams AR; Hatzistergos KE; Addicott B; McCall F; Carvalho D; Suncion V; Morales AR; Da Silva J; Sussman MA; Heldman AW; Hare JM Circulation; 2013 Jan; 127(2):213-23. PubMed ID: 23224061 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts. Zhang L; Chen B; Zhao Y; Dubielecka PM; Wei L; Qin GJ; Chin YE; Wang Y; Zhao TC J Biol Chem; 2012 Nov; 287(47):39338-48. PubMed ID: 23024362 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium. Zhao YT; Du J; Chen Y; Tang Y; Qin G; Lv G; Zhuang S; Zhao TC Stem Cell Res Ther; 2015 Dec; 6():259. PubMed ID: 26704423 [TBL] [Abstract][Full Text] [Related]
26. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. Shibata R; Izumiya Y; Sato K; Papanicolaou K; Kihara S; Colucci WS; Sam F; Ouchi N; Walsh K J Mol Cell Cardiol; 2007 Jun; 42(6):1065-74. PubMed ID: 17499764 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Glass C; Singla DK Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2038-49. PubMed ID: 21856911 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Repeated Doses of C-kit-Positive Cardiac Cells versus a Single Equivalent Combined Dose in a Murine Model of Chronic Ischemic Cardiomyopathy. Li Q; Guo Y; Nong Y; Tomlin A; Gumpert A; Zhu X; Hassan SA; Bolli R Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808720 [TBL] [Abstract][Full Text] [Related]
29. Sorafenib stimulates human skin type mast cell degranulation and maturation. Mizukami Y; Sugawara K; Kira Y; Tsuruta D J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624 [TBL] [Abstract][Full Text] [Related]
30. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140 [TBL] [Abstract][Full Text] [Related]
31. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK. Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788 [TBL] [Abstract][Full Text] [Related]
32. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL. Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258 [TBL] [Abstract][Full Text] [Related]
33. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Louandre C; Marcq I; Bouhlal H; Lachaier E; Godin C; Saidak Z; François C; Chatelain D; Debuysscher V; Barbare JC; Chauffert B; Galmiche A Cancer Lett; 2015 Jan; 356(2 Pt B):971-7. PubMed ID: 25444922 [TBL] [Abstract][Full Text] [Related]
34. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Lehrke S; Mazhari R; Durand DJ; Zheng M; Bedja D; Zimmet JM; Schuleri KH; Chi AS; Gabrielson KL; Hare JM Circ Res; 2006 Sep; 99(5):553-60. PubMed ID: 16873716 [TBL] [Abstract][Full Text] [Related]
36. Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo. Coriat R; Nicco C; Chéreau C; Mir O; Alexandre J; Ropert S; Weill B; Chaussade S; Goldwasser F; Batteux F Mol Cancer Ther; 2012 Oct; 11(10):2284-93. PubMed ID: 22902857 [TBL] [Abstract][Full Text] [Related]
37. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755 [TBL] [Abstract][Full Text] [Related]
38. Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration. Ma W; Tao L; Wang X; Liu Q; Zhang W; Li Q; He C; Xue D; Zhang J; Liu C Cell Physiol Biochem; 2016; 39(5):1837-1849. PubMed ID: 27744426 [TBL] [Abstract][Full Text] [Related]
39. Vinexin-β exacerbates cardiac dysfunction post-myocardial infarction via mediating apoptotic and inflammatory responses. Liu X; Wan N; Zhang XJ; Zhao Y; Zhang Y; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H Clin Sci (Lond); 2015 Jun; 128(12):923-36. PubMed ID: 25658191 [TBL] [Abstract][Full Text] [Related]
40. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction. Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]